Skip to main content

Table 1 Demographic, clinical and biochemical characteristics between ACS and SAP group

From: The relationship between IL-6 levels and the angiographic severity of coronary artery disease following percutaneous coronary intervention in acute coronary syndrome patients

Variables ACS (n = 201) SAP (n = 145) P value
Age, years 65 (57–71) 65 (57–72) .323
Male gender, n (%) 136 (67.7%) 83 (57.2%) .047
Hypertension, n (%) 127 (63.2%) 95 (65.5%) .655
Diabetes, n (%) 49 (24.4%) 27 (18.6%) .202
Smoking, n (%) 30 (14.9%) 14 (9.7%) .147
BMI, kg/m2 24.8 ± 3.3 24.7 ± 3.6 .916
WBC, 109/L 6.7 (5.4–8.1) 5.9 (4.8–6.9) < .001
NEUT, 109/L 4.1 (3.4–5.6) 3.5 (2.7–4.4) < .001
LYM, 109/L 1.7 (1.3–2.1) 1.6 (1.3–2.0) .293
NLR 2.4 (1.8–3.4) 2.1 (1.7–2.6) .001
Platelet, 109/L 175 (142–217) 166 (128–203) .041
RDW 12.8 (12.5–13.4) 13.0 (12.6–13.3) .470
Hemoglobin, g/L 129.5 ± 16.4 129.2 ± 15.7 .896
IL-6, pg/ml 7.5 (4.8–10.9) 3.8 (2.4–5.3) < .001
hs-CRP, mg/l 6.0 (1.7–11.2) 1.2 (0.5–2.8) < .001
Glucose, mmol/L 5.7 ± 2.3 5.4 ± 1.6 .202
TC, mmol/L 3.9 ± 1.0 3.9 ± 0.9 .858
Triglyceride, mmol/L 1.4 (1.0–1.9) 1.3 (0.9–1.8) .280
HDL-c, mmol/L 1.2 (1.0–1.4) 1.3 (1.1–1.5) .001
LDL-c, mmol/L 2.1 (1.6–2.8) 2.1 (1.5–2.7) .706
apoB, g/L 0.8 (0.6–1.0) 0.8 (0.6–0.9) .317
apoA1, g/L 1.1 (0.9–1.2) 1.2 (1.0–1.3) < .001
Lp(a), mg/L 227.2 (102.5–469.4) 210.7 (90.5–386.5) .208
Creatinine, umol/L 69.0 (57.7–85.7) 64.6 (53.7–76.0) .012
eGFR, ml/min 86.2 (67.6–112.6) 91.4 (66.7–112.9) .454
Albumin, g/L 39.0 ± 3.4 39.8 ± 3.5 .034
Fibrinogen, g/L 3.0 (2.6–3.9) 2.9 (2.4–3.2) .001
D-Dimer, ug/ml 0.3 (0.2–0.4) 0.3 (0.2–0.5) .066
LVEF, % 62.0 (58.0–65.0) 64.0 (60.0–66.0) .001
  1. ACS, acute coronary syndrome; SAP, stable angina pectoris; BMI, Body Mass Index; WBC, white blood cell; NEUT, neutrophil; LYM, lymphocyte; NLR, the neutrophil to the lymphocyte ratio; RDW, red cell distribution width; IL-6, interleukin 6; hs-CRP, high-sensitivity C-reactive protein; TC, total cholesterol; HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol; apoB, apolipoprotein B; apoA1, apolipoprotein A1; apoB/apoA1, the apoB to the apoA1 ratio; Lp(a), lipoprotein a; eGFR, estimated glomerular filtration rate; LVEF, left ventricular ejection fraction